LUNG NEOPLASMS
Clinical trials for LUNG NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new LUNG NEOPLASMS trials appear
Sign up with your email to follow new studies for LUNG NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on tough cancers
Disease control OngoingThis early-phase study tests a new treatment called KSQ-001EX for people with advanced solid tumors like melanoma, lung, or head and neck cancers. The treatment uses a patient's own immune cells, which are modified in a lab to work better against cancer. The main goal is to see i…
Matched conditions: LUNG NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Last-Resort drug access opens for rare lung cancer patients
Disease control NO_LONGER_AVAILABLEThis program gives adults with advanced or spreading ROS1-positive non-small cell lung cancer access to taletrectinib when they cannot use approved treatments or join ongoing studies. It is for patients who, in their doctor's opinion, might benefit from the drug. The goal is to p…
Matched conditions: LUNG NEOPLASMS
Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
Shorter proton blasts may boost lung cancer survival
Disease control OngoingThis study tests a new way to give proton radiation for stage II-III non-small cell lung cancer. Instead of daily low doses over many weeks, patients get higher doses over a shorter time (hypofractionation) along with standard chemotherapy. The goal is to find the safest high dos…
Matched conditions: LUNG NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated May 26, 2026 08:26 UTC
-
New drug combo shows promise for Hard-to-Treat lung cancer
Disease control OngoingThis study tests whether adding the drugs pembrolizumab and olaparib to standard chemoradiation helps people with stage III non-small cell lung cancer that cannot be surgically removed. About 870 participants will receive either pembrolizumab with or without olaparib after chemor…
Matched conditions: LUNG NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 08:23 UTC
-
New combo therapy shows promise for common lung cancer mutation
Disease control OngoingThis study looks at how well the drug osimertinib combined with chemotherapy works as the first treatment for people with advanced EGFR-mutant non-small cell lung cancer. It involves 532 adults with stage IIIB, IIIC, or IV disease who have not had prior therapy. The goal is to me…
Matched conditions: LUNG NEOPLASMS
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Robot-Assisted lung biopsy could boost diagnostic accuracy
Diagnosis OngoingThis study compares a new technique that combines cone-beam CT scans with a robot-assisted bronchoscope against standard methods for taking lung tissue samples. The goal is to see if the new approach improves the chance of getting a clear diagnosis for suspicious lung spots or ot…
Matched conditions: LUNG NEOPLASMS
Phase: NA • Sponsor: University of Zurich • Aim: Diagnosis
Last updated May 20, 2026 11:53 UTC
-
Breathing easy: new tech tracks lung tumors in real time
Knowledge-focused OngoingThis study tests a new technology that adjusts the radiation beam to follow lung tumors as they move when a person breathes during treatment. About 20 adults with early-stage lung cancer or limited lung metastases will take part. The goal is to see if the system works reliably an…
Matched conditions: LUNG NEOPLASMS
Phase: NA • Sponsor: Royal North Shore Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
Blood tests could tailor lung cancer therapy
Knowledge-focused OngoingThis study looks at cancer cells found in the blood of people with advanced lung cancer. Researchers want to see if these cells have certain DNA repair problems that could help choose the right treatment. About 80 patients will give blood samples to help build tumor models and te…
Matched conditions: LUNG NEOPLASMS
Sponsor: Shadia Jalal • Aim: Knowledge-focused
Last updated May 26, 2026 08:31 UTC
-
New lung biopsy tool tested in over 1,300 patients
Knowledge-focused OngoingThis study looks at how well the Ion Endoluminal System works in everyday medical practice for taking tissue samples from lung spots or nodules. About 1,300 adults who need a lung biopsy or lesion localization will be observed. The goal is to see how often the system correctly di…
Matched conditions: LUNG NEOPLASMS
Sponsor: Intuitive Surgical • Aim: Knowledge-focused
Last updated May 26, 2026 08:28 UTC
-
Lung cancer scan debate: every 6 months or once a year?
Knowledge-focused OngoingThis study follows over 1,800 people who finished treatment for early-stage lung cancer to see how often they get follow-up CT scans. Researchers want to know if getting scans every 6 months helps find new cancers earlier or improves survival compared to yearly scans. The goal is…
Matched conditions: LUNG NEOPLASMS
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated May 26, 2026 08:26 UTC
-
Can doctor training boost lung cancer care in smaller cities?
Knowledge-focused OngoingThis study looks at whether educating doctors in small and mid-sized city hospitals about standard guidelines helps improve testing and treatment for people with advanced non-small cell lung cancer. About 1000 patients will be observed to see if more get the right molecular tests…
Matched conditions: LUNG NEOPLASMS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 08:19 UTC
-
New imaging technique may reduce lung damage from cancer radiation
Knowledge-focused OngoingThis study looks at whether a special CT scan (4DCT) can help doctors avoid giving too much radiation to healthy parts of the lung during lung cancer treatment. Researchers will compare standard radiation plans with new plans that protect well-working lung areas. The goal is to s…
Matched conditions: LUNG NEOPLASMS
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC